Response to Comment on Kazda et al. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249. (Record no. 26674462)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01419 a2200397 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517130343.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201801s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1935-5548 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.2337/dci16-0030 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Kazda, Christof M |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180108 |
| 245 00 - TITLE STATEMENT | |
| Title | Response to Comment on Kazda et al. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Diabetes care |
| Date of publication, distribution, etc. | 11 2016 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | e199-e200 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biphenyl Compounds |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Diabetes Mellitus, Type 2 |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Glucagon |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptors, Glucagon |
| General subdivision | antagonists & inhibitors |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ding, Ying |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kelly, Ronan P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Garhyan, Parag |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shi, Chunxue |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lim, Chay Ngee |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fu, Haoda |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Watson, David E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lewin, Andrew J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Landschulz, William H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Deeg, Mark A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moller, David E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hardy, Thomas A |
| 773 0# - HOST ITEM ENTRY | |
| Title | Diabetes care |
| Related parts | vol. 39 |
| -- | no. 11 |
| -- | p. e199-e200 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.2337/dci16-0030">https://doi.org/10.2337/dci16-0030</a> |
| Public note | Available from publisher's website |
No items available.